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Abstract
LRFN2 encodes a synaptic adhesion-like molecule that physically interacts with N-methyl-
D-aspartate (NMDA) receptor 1 and its scaffold proteins. Previous studies in humans and
mice have demonstrated its genetic association with neurodevelopmental disorders such as
learning deficiency and autism. In this study, we showed that Lrfn2-deficient (KO) mice
exhibit abnormalities of erythropoietic systems due to altered NMDA receptor function. In
mature Lrfn2 KO male mice, peripheral blood tests showed multilineage abnormalities,
including normocytic erythrocythemia, and reduced platelet volume. Colony forming unit
assay using bone marrow cells revealed decreases in the counts of erythrocyte progenitors
(CFU-E) as well as granulocytes and monocyte progenitors (CFU-GM). Whole bone marrow
cell staining showed that serum erythropoietin (EPO) level was decreased and EPO recep-
tor-like immunoreactivity was increased. Flow cytometry analysis of bone marrow cells
revealed increased early erythroblast count and increased transferrin receptor expression in
late erythroblasts. Further, we found that late erythroblasts in Lrfn2 KO exhibited defective
NMDA receptor-mediated calcium influx, which was inhibited by the NMDA receptor antago-
nist MK801. These results indicate that Lrfn2 has biphasic roles in hematopoiesis and is
associated with the functional integrity of NMDA receptors in hematopoietic cells. Further-
more, taken together with previous studies that showed the involvement of NMDA receptors
in hematopoiesis, the results of this study indicate that Lrfn2 may regulate erythropoiesis
through its regulatory activity on NMDA receptors.
Introduction
Lrfn2 (also known as SALM [synaptic adhesion like molecule] 1) is a member of the Lrfn fam-
ily proteins, which are known to be cell adhesion molecules that regulate neuronal and synap-
tic development in the brain [1]. Lrfn2 physically interacts with ion channels forming a
glutamate receptor called N-methyl-D-aspartate receptor 1 (NMDAR1, also known as GluN1
or Grin1) [1] as well as a synaptic scaffold protein PSD95 (post synaptic density protein 95,
also known as Dlg4) [1–3]. Recent genetic studies have linked human LRFN2 to autism-
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spectrum disorders [4], working memory deficits [5], and anti-social personality disorder [6];
moreover, mouse Lrfn2 deficiency results in altered synaptic plasticity and abnormal social
behaviors [4,7].
The above studies addressed the roles of the Lrfn2 family proteins in the nervous system,
whereas Castellanos et al. [8] investigated the role of the Lrfn2 protein in hematopoiesis.
According to their study, Lrfn2 overexpression, in a colony formation assay using murine
bone marrow (BM) cells, increased erythroid progenitor-containing colonies (BFU-E) as well
as colonies containing common progenitors for granulocyte/erythrocyte/macrophage/mega-
karyocyte (CFU-GEMM), suggesting increased erythropoiesis due to Lrfn2 overexpression
[8]. They also reported that Lrfn2 overexpression in BM cells causes the overgrowth of an
unclassifiable “bizarre” cell type [8]. These results, collectively, revealed that overexpressed
Lrfn2 could affect hematopoiesis. However, the physiological significance of Lrfn2 remains
unclear due to the absence of loss-of-function analysis. Moreover, there have been no mecha-
nistic models to explain the Lrfn2-mediated control of hematopoiesis.
On the other hand, recent studies revealed that NMDA receptors play significant roles in
hematopoiesis [9]. NMDA receptor subunits are expressed in megakaryocytes and erythroid
cells and function as ion channels, similar to their neuronal counterparts [9]. NMDAR1 defi-
ciency impairs differentiation of megakaryocytic-erythroid progenitor (MEP)-like leukemia
cells (Meg-01 cells) [10]. It is proposed that the NMDA receptors balance both megakaryocytic
and erythroid cell fates at the level of a bipotential MEP [9]. These facts attract our attention to
the functional relationship between Lrfn2 and NMDA receptors in hematopoiesis.
In this study, we examined the hematopoietic phenotype of Lrfn2-deficient (knockout, KO)
mice. Our results indicated that Lrfn2 is involved in the control of erythropoiesis. We also
found dysregulation of NMDA receptor function in late erythroblasts and discussed a potential
mechanism to explain the Lrfn2-mediated erythropoiesis control.
Materials and methods
Animals
All animal experiments were approved by the Animal Care and Use Committee of Nagasaki
University (approval number 1803271441–5) and carried out in accordance with the guide-
lines for animal experimentation at Nagasaki University. Lrfn2 KO (Lrfn2-/-) mice were cre-
ated and genotyped as described [4], and were backcrossed to C57BL/6J mice for more than
ten generations before commencement of the experiments. Adult male mice 3–27 M-old were
used in this study. Mice were maintained on a 12-h dark/light cycle (7 a.m./7 p.m.) with food
and water provided ad libitum. Mice older than 7 M were subjected to behavioral assays before
the study. The behavioral tests included open field test, social discrimination test, and fear-
conditioning test, all of which were carried out equally for age-matched Wild type (WT) and
KO mice. WT littermates (Lrfn2+/+) are used as the control group in all analyses. A total of 67
WT and 67 KO mice were used in this study. Each sample was derived from a single mouse
without pooling. Common mice were used partly between the peripheral blood test and the
other tests. Common mice were used between spleen weight measurement and (calcium mea-
surement test or colony assay). Sample sizes for each experiment were determined such that
the power and significance in two sided-test were 80% and 5%, respectively [11]. However, the
number of samples from animals were minimized empirically.
Peripheral blood test
Peripheral blood (100–200 μL) was collected from a mouse at 3M (2.0–4.3 M-old), 6M (5.8–
7.2 M-old), and 12M (10.3–13.1 M-old) after birth, by means of cheek bleeding [12], and
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stored in BD microtainer tubes (Beckton, Dickinson and Company, Franklin Lakes, NJ) con-
taining EDTA. Some mice were repeatedly bled at multiple stages. Hematological profiles were
determined using a veterinary hematology analyzer (thinka CB-1010, ARKRAY, Kyoto,
Japan).
Measurement of serum EPO
Sera (20–60 μL) were prepared from the peripheral blood collected from 12–14 M-old mice by
cheek bleeding and stored at -80˚C. The samples were diluted six-fold, and EPO measurement
was done using Quantikine ELISA Mouse Erythropoietin (R&D Systems, Minneapolis, MN),
according to manufacturer’s instructions. All samples were measured in duplicate.
Colony forming unit (CFU) assay
Femurs were isolated from 3–6 M-old mice (BM cells) or 11–12 M-old mice (spleen cells).
Cells were plated in methyl cellulose MethoCult medium (M3434, M3234, STEMCELL Tech-
nology, Vancouver, Canada), as per the manufacturer’s instructions. For BFU-E, CFU-GM,
and CFU-GEMM, 1.0×104 BM cells or 4.0×105 spleen cells obtained from a mouse were cul-
tured in two 35 mm dishes in the presence of SCF, IL-3, IL-6, and EPO (M3434) for 12 or 13
days before observation. For CFU-E, 6.8×105 BM or 4.0×105 spleen cells obtained from a
mouse were cultured in three 35 mm dishes containing MethoCult medium (M3234) supple-
mented with 10 U/mL rhEPO for 2 days before observation. BM cells were not treated to lyse
red blood cells. Images of the entire 35-mm dish field were obtained using the image-stitching
function of the BZ-X800 microscope (Keyence, Osaka, Japan). Colonies were counted by an
observer who was blinded to the genotypes.
Flow cytometric analysis
For the analysis of erythroid progenitors in BM, CD71/TER119 double labeling was performed
as described [13,14]. BM cells were isolated from femurs of 18–22 M-old mice and washed
with 5% fetal bovine serum-containing Dulbecco’s phosphate buffered saline without calcium
and magnesium (5% FBS-PBS). After blocking the Fc receptor using anti-mouse CD16/32
antibodies (Biolegend, San Diego, CA), BM cells were incubated on ice for 1 h with FITC-
Ter119 (Biolegend) and PE-CD71 (Biolegend) after blocking Fc receptors. Control samples
were incubated with the FITC-IgG2b and PE-IgG1 isotype control antibodies (Biolegend).
7AAD dye (COSMO BIO, Tokyo, Japan) was added 5 min before flow cytometry analysis to
exclude dead cells. Flow cytometry was performed using the BD LSRFortessa X-20 cell ana-
lyzer (BD Biosciences). All Ter119-positive cells were classified into four subsets: ProE
(Ter119medCD71high), EryA (Ter119highCD71highFSChigh), EryB (Ter119highCD71highFSClow),
and EryC (Ter119highCD71lowFSClow), corresponding to morphologically recognized proery-
throblasts and basophilic, polychromatic, and orthochromatic erythroblasts, respectively.
Intracellular calcium concentration measurement
Calcium concentration of BM cells was measured using flow cytometry, according to a method
based on the one described by Hanggi et al. [15]. BM cells were isolated from femurs of 6–12
M-old or 19–22 M-old mice and washed with 5% FBS-PBS. Live cell numbers were counted
using the TC20 cell counter (Bio-Rad, Hercules, CA) with trypan blue staining. BM cells
(1×106) were suspended in 0.1 mL of erythroid progenitor culture medium [16] consisting of
Iscove’s modified Dulbecco’s medium (IMDM) containing 0.51 mM glutamic acid, 0.40 mM
glycine, 1.5 mM calcium chloride (FUJIFILM Wako, Osaka, Japan), 15% FBS (Thermo Fisher
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Scientific, Waltham, MA), Insulin-Transferrin-Selenium (ITS-G, Thermo Fisher Scientific),
0.45 mM α-monothioglycerol (FUJIFILM Wako), and 50 μg/ml ascorbic acid (Sigma-Aldrich,
St. Louis, MO). The cells were then loaded with 3 μM Fluo4-AM (DOJINDO LAB, Kuma-
moto, Japan) for 30 min at 37˚C, followed by further 30 min incubation at 37˚C with the fol-
lowing antibodies: APC-Ter119 (Biolegend) and PE-CD71 (Biolegend). For NMDA receptor
antagonist treatment, MK-801 (final 80 μM, Cayman Chemical, Ann Arbor, MI) was added to
the cell suspensions just before antibody addition and incubated for 30 min at 37˚C. The cell
culture medium was replaced by a flow cytometry solution (pH 7.35) containing (in mM) 135
NaCl, 5 KCl, 5 HEPES, 10 D-glucose, and 2 CaCl2. The cells were washed twice with the flow
cytometry solution before measurement. Agonist-induced Ca2+ uptake was recorded as the
response to the administration of 150 μM NMDA and 50 μM glycine (NMDA/GLY) to the
flow cytometry solution containing the cells. The time window for the measurement was 7 to
37 sec after the NMDA/GLY addition. All assays were performed in duplicate.
Immunostaining analysis
BM cells were fixed with 4% paraformaldehyde for 20 min at room temperature and the cells
were rinsed and suspended in the culture medium. 1×106 cells were pelleted in microfuge and
resuspended in 0.2 mL of deionized H2O. 0.1 mL of the cell suspension was added to a cham-
ber (48 mm2) in 3-chamber cytofuge cassette (StatSpin Cytofuge 2, Nihon Rufuto, Tokyo,
Japan) on MAS-coated slide glass (Matsunami Glass, Osaka, Japan), and settled onto glass sur-
face by centrifugation at 1000 rpm for 4 min. The cells were briefly dried on a hot plate at 30
˚C. The cells were then immersed in PBS, incubated in a blocking buffer (5% donkey serum,
0.1%TX100, PBS) for 45 min at room temperature, and reacted with goat anti mouse EpoR
antibody (AF1390, R&D Systems, 1/200 in the blocking buffer) at 4˚C overnight. The primary
antibody was detected by Alexa488-conjugated donkey anti-goat IgG (Jackson ImmunoRe-
search, West Grove, PA). After mounted in VectaShield with DAPI (Vector Laboratories),
images were taken by LSM800 confocal microscope (ZEISS, Oberkochen, Germany). Images
were analysed by using Image J (https://imagej.nih.gov/ij/index.html).
Statistical analysis
All data were expressed as the mean ± standard deviation (SD). Statistical analyses of all data were
performed using two tailed Student’s t-test for two group comparisons, unless otherwise noted.
Two-way analysis of variance was used to evaluate the effect of MK-801. Percentage values in the
results section indicate the percentage of (KO mean value -WT mean value) when WT mean val-
ues are defined as 100%. A P value of less than 0.05 was considered statistically significant.
Results
Hematological abnormalities in Lrfn2 KO mice
To address the role of Lrfn2 in hematopoiesis, we first determined the hematological profiles
of Lrfn2 KO mice in the 3 M, 6 M, and 12 M old groups in comparison to littermate WT mice.
The results (Fig 1, S1 Table) revealed multilineage abnormalities. With regards to erythrocyte-
related indexes, erythrocyte numbers (Fig 1A), hemoglobin (Fig 1B), and hematocrit (Fig 1C)
were increased in both 6 M (11.3%, 11.2%, and 12.0%, respectively) and 12 M (6.4%, 7.7%, and
6.7%, respectively) old groups; moreover, 3 M old mice showed the same tendency (6.7%,
5.3%, and 6.2%, respectively). No significant difference in the mean corpuscular volume was
observed among the groups, indicating normocytic erythrocythemia in Lrfn2 KO mice. How-
ever, mean corpuscular hemoglobin level in 3 M old Lrfn2 KO mice was slightly (1.5%)
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reduced in comparison to WT mice. In the context of platelet-related indexes, reduced platelet
volumes were observed in both 6 M (- 6.5%) and 12 M (- 4.7%) old mice (Fig 1D). Among leu-
kocyte-related indexes, the total leukocyte number was decreased (- 21%) in 6 M old mice (Fig
1E), with reduced counts of granulocytes and lymphocytes (S1 Table).
Colony forming units were reduced in Lrfn2 KO
To investigate whether any relevant phenotypes exist in the BM of Lrfn2 KO mice, we first per-
formed colony forming unit assay. BM cells were cultured in methyl cellulose medium and the
resultant colonies were counted. As shown in Fig 2, the number of granulocyte/macrophage-
colony forming units was decreased in the Lrfn2 KO group (- 26%, P = 0.012). The erythroid-
burst forming unit (BFU-E) showed a marginal decrease (- 17%, P = 0.27), and the erythroid-
colony forming unit (CFU-E) was significantly decreased in comparison to WT group (- 20%,
Fig 1. Hemogram of Lrfn2 KO mice. Complete blood count of male Lrfn2 WT (open bars) and KO (closed bars) mice aged 3 M (2.0–
4.3 M-old; WT, n = 6; KO, n = 7), 6 M (5.8–7.2 M-old; WT, n = 5; KO, n = 6), and 12 M (10.3–13.1 M-old; WT, n = 16; KO, n = 14). (A)
Erythrocyte count. (B) Hematocrit. (C) Hemoglobin. (D) Mean platelet volume. (E) Leukocyte count. Additional results are indicated
in S1 Table. Open bar, WT; closed bar, KO; error bar, SD. Each value from a mouse is indicated by circles. P values indicate those
obtained by two tailed t-tests.
https://doi.org/10.1371/journal.pone.0245624.g001
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P = 0.018). We also performed colony forming unit assay using spleen cells and found that
CFU-E tended to decrease (- 40%, P = 0.18) in Lrfn2 KO mice.
Both BFU-E cells and CFU-E cells represent two differentiation stages in early erythropoie-
sis [pro-erythroblasts, early (basophilic) erythroblasts, mid (polychromatic) erythroblasts, and
Fig 2. Colony forming unit (CFU) assay. BM cells from 3–6 M-old male WT (n = 6) and Lrfn2 KO (n = 5 or 6) mice
and spleen cells from 11–12 M-old male WT (n = 5) and Lrfn2 KO (n = 6) mice were used for the assay. Mean colony
numbers in a dish are indicated. Open bar, WT; closed bar, KO; error bar, SD. Each value from a mouse is indicated by
circles. P values indicate those obtained by two tailed t-tests.
https://doi.org/10.1371/journal.pone.0245624.g002
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late (orthochromatic) erythroblasts]. BFU-E cells require both stem cell factors and EPO
whereas CFU-E cells require only EPO [17]. A recent study involving transcriptome analysis
showed that BFU-E and CFU-E represent CD45+GPA-IL-3R-CD34+CD36-CD71low cells and
CD45+GPA-IL-3R-CD34-CD36+CD71high cells, respectively, and suggested that erythroid dif-
ferentiation progresses in the following order: CD34+ hematopoiesis progenitor cells!
BFU-E cells! CFU-E cells! pro-erythroblasts [17]. Thus, the colony forming unit assay
demonstrated that Lrfn2 KO mice exhibited either reduced counts of BFU-E cells or acceler-
ated differentiation to pro-erythroblast, or both, irrespective of the increased count of mature
erythrocytes. In any case, it was thought that early phase of erythropoiesis was impaired in
Lrfn2 KO mice.
Serum EPO level was reduced in Lrfn2 KO mice
As erythrocythemia can be secondarily caused by increased EPO levels [18], we measured the
serum EPO levels in Lrfn2 KO mice (Fig 3A) and found that it was significantly decreased (-
6.7%, P = 0.022). Therefore, erythrocytosis in Lrfn2 KO mice was considered to be caused by
the alteration of a mechanism intrinsic to erythroid progenitors. Interestingly, 10–12 M-old
Lrfn2 KO mice showed significant body weight loss (-14%, P = 0.00054) (Fig 3B), which was
severer than that observed in 8 weeks-old mice (- 6.0%, P = 0.022) [4]. Because splenomegaly
is included in the diagnostic criteria of polycythemia vera [19], we measured the weight of the
spleen (Fig 3B). In both the 10–12 M-old and 19–27 M-old age groups, the average weights of
spleens were comparable between WT and KO mice (Fig 3B). However, the weights of spleen
from KO mice were less divergent than from WT mice in the 10–12 M-old age group (P = 9.0
×10−5 in f-test) but more divergent in the 19–27 M-old age group (P = 0.041 in f-test) (Fig 3B),
indicating hematological dysregulation that is distinct from polycythemia vera. The increased
serum EPO level, together with Lrfn2 overexpression [8], led us to hypothesize that Lrfn2 defi-
ciency directly affects erythropoiesis in vivo.
Fig 3. Erythropoietin and spleen weight abnormalities in Lrfn2 KO. (A) Erythropoietin levels in 12–14 M-old Lrfn2
WT (n = 12) and KO (n = 15) mice. (B) Body weight (left) and spleen weight normalized to the body weight (right) of
Lrfn2 KO and WT mice aged 10–12 M-old (left; WT, n = 12; KO, n = 15) or 19–27 M-old (right; WT, n = 7; KO, n = 6)
stage. Open bar, WT; closed bar, KO; error bar, SD. Each value from a mouse is indicated by circles. P values indicate
those obtained by two tailed t-tests (A) or f-tests (f-test in B).
https://doi.org/10.1371/journal.pone.0245624.g003
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Abnormalities of the late erythropoiesis in Lrfn2 KO mice
We next examined the erythrocyte progenitors in the BM of Lrfn2 KO mice using flow cytom-
etry. Double labeling with CD71, a transferrin receptor, and TER119, a cell surface antigen
specific to mature erythroid cells, enabled us to define subsets of erythroid cell lineage [13].
We investigated Lrfn2 KO and WT BM cells from 6–12 M and 18–22 M old mice (Fig 4, S2
Table). In terms of cell counts, the number of early erythroblasts (EryA) in the Lrfn2 KO
group was larger (12%, P = 0.0089) than that in the WT group, whereas the number of total
erythroid lineage cells (TER119+ cells) was comparable in both groups (Fig 4B, S2 Table). Fur-
thermore, the expression of CD71 in late erythroblasts (EryC) was higher in the Lrfn2 KO
group than in the WT group (21%, P = 0.0037) (Fig 4D, S2 Table). Proerythroblast (proE) side
scattering (- 8.3%, P = 0.060) tended to be lower in Lrfn2 KO (Fig 4C, S2 Table). These results
suggested that the late phase of erythropoiesis was affected by the lack of Lrfn2.
Altered NMDA receptor-mediated calcium influx in Lrfn2 KO erythroid
progenitors
We further investigated the mechanism by which Lrfn2 controls erythropoiesis. We hypothe-
sized that NMDA receptor was involved in Lrfn2-regulated erythropoiesis because previous
studies have demonstrated the NMDAR1-binding ability of Lrfn2 [1] and the essential roles of
NMDA receptors in human erythroid precursor cells [15]. To examine the function of NMDA
receptor in Lrfn2 KO BM cells, we measured the intracellular Ca2+ level using the membrane
permeable Ca2+-sensitive dye Fluo-4 AM. BM cells were loaded with Fluo-4 AM, labeled with
TER119 and CD71 antibodies, and stimulated with the NMDA receptor agonists NMDA and
glycine (NMDA/GLY) immediately before flow cytometry (Fig 5A).
NMDA receptor-induced changes in Ca2+ level and the reduction of Ca2+ level caused by
pretreatment with the NMDA receptor non-competitive antagonist MK-801 were measured
for two age groups (6–12 M and 19–22 M) in mice (Fig 5B). In WT BM cells, NMDA-induced
changes were observed in the Ca2+ levels of mid erythroblasts (EryB, 19–22 M) and late eryth-
roblasts (EryC, 6–12 M and 19–22 M). MK-801-induced suppression was observed in late
erythroblasts (EryC, 6–12 M), in which NMDA/GLY induced lower ΔF/F in KO BM cells
(mean ± SD, 106 ± 119%) than in WT cells (mean ± SD, 304 ± 158%) (6–12 M, P = 0.013);
notably, the effects of MK-801 on the NMDA/GLY response were different between KO cells
and WT cells (19–22 M, P = 0.019).
Moreover, the effects of MK-801 were different between WT and KO cells in the 6–12 M
group (P = 0.012 in two-way ANOVA of ΔF/F, including genotype [WT, KO] and treatment
[NMDA/GLY, NMDA/GLY+MK801]). In mid erythroblasts (EryB) of the 19–22 M age
group, the variance of NMDA/GLY was larger in KO cells than that in WT cells (P = 0.0027
in f-test). These results indicated that Lrfn2 KO BM cells had impaired NMDAR function in
late erythroblasts, consistent with the larger NMDA/GLY response variance (6–12 M,
P = 0.0063 in f-test) and MK-801-induced suppression variance (19–22 M, P = 0.021 in f-
test) in WT erythroid cells (TER119+) compared to those in KO erythroid cells; moreover,
the NMDA receptor functions were limited to late (6–12 M and 19–22 M) or mid (19–22 M)
erythroblasts.
In addition, Ca2+ analysis uncovered an aging effect on the NMDA receptor functions in
mouse erythroid progenitors (Fig 5B). When compared between 6–12 M and 19–22 M WT
erythroblasts, NMDA/GLY-induced ΔF/F was found to be lower in the 19–22 M group
(mean ± SD, 26 ± 31%) than in the 6–12 M group (mean ± SD, 304 ± 158%, P = 0.0015)
whereas the corresponding difference in the KO group was not so clear (P = 0.057).
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Erythropoietin receptor protein level was increased in Lrfn2 KO BM cells
To further clarify the basis of erythrocythemia in Lrfn2 KO cells, we examined EPO receptor
(EpoR) expression. Immunostaining of BM cells revealed significant increase in EpoR-immu-
nopositive particle count (68%, P = 0.048) (Fig 6) with comparable particle sizes (16%,
Fig 4. Flow cytometry analysis of Lrfn2 KO BM cells. BM cells from 18–22 M-old Lrfn2 WT (n = 8) and KO (n = 7) mice were subjected to
CD71/TER119 flow cytometry. (A) Gating strategy. (B) Cell count, number of cells out of 10,000 living cells (7AAD-negative). (C) SSC, side
scatter area. (D) CD71, mean immunofluorescence intensity (arbitrary unit) of anti-CD71-PE. TER119, mean immunofluorescence intensity
(arbitrary unit) of anti-Ter119-FITC; FSC, forward scatter area. In B-D, Open bar, WT; closed bar, KO; error bar, SD. Each value from a
mouse is indicated by circles. P values were obtained by two tailed t-tests Additional results are indicated in S2 Table.
https://doi.org/10.1371/journal.pone.0245624.g004
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Fig 5. Altered NMDA receptor-mediated Ca2+ influx in Lrfn2 KO mice. Bone marrow cells from 6–12 M-old (top; WT, n = 8; KO,
n = 8) or 19–22 M-old (bottom; WT, n = 9; KO, n = 7) WT and Lrfn2 KO mice were subjected to Fluo4-based intracellular Ca2+
PLOS ONE Erythropoiesis and erythroblastic NMDAR-mediated calcium influx in Lrfn2 KO mice
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P = 0.44) (Fig 6) and intensities (0.3%, P = 0.12). We also performed qPCR analysis using
FACS fractionated proE, EryB, and EryC (S1 Fig). However, significant differences between
WT and KO cells were not found in genes that critically regulate erythrocyte counts (EpoR and
Jak2), encode NMDA receptor subunits (Grin1 and Grin2c), or change in Lrfn2 KO EryC
(Tfrc). Jak2 mediates EpoR signaling and is a causal gene of polycythemia vera [19]. Tfrc
encodes transferrin receptor (CD71), while Grin1 and Grin2c encode the NMDA receptor sub-
units NMDAR1 and NR2C, respectively. Grin2c expression tended to be higher in late eryth-
roblasts than in mid erythroblasts (S2 Fig). Histological analysis of BM and spleen did not
reveal clear differences between WT and KO cells (S3 Fig).
Discussion
This study revealed the importance of Lrfn2 in the regulation of erythropoiesis. Hemogram
and BM cell analyses of Lrfn2 KO mice revealed multilineage abnormalities. In erythroid cells,
normocytic erythrocythemia, decreased CFU-E, increased early erythroblast populations, and
impaired late erythroblast differentiation were observed. In addition, we observed dysregula-
tion of NMDA receptors involved in erythropoiesis.
Previous studies have elucidated the role of NMDA receptors in erythropoiesis. NMDA
receptors have been detected in rat erythrocytes [20] and human erythroid precursor cells
[21]. Moreover, NMDA receptors play a dual role in erythropoiesis, supporting survival of
mid (EryB) erythroblasts and contributing to the Ca2+ homeostasis in late (EryC) erythroblasts
and circulating erythrocytes [15]. In a recent study using Meg-01 cells (models of human
megakaryocytic and erythroid progenitors (MEP)), NMDAR1 KO (Meg-01-GRIN1-/-) cells
underwent atypical differentiation toward erythropoiesis, which is associated with increased
basal ER stress and cell death [10]. Thus, NMDAR1 function may be involved in erythropoiesis
at multiple stages, from the lineage determination to the late differentiation stage. In addition,
calcium signaling, such as EPO signaling [22–24], PIEZO1 signaling [25], and erythroid enu-
cleation [26], plays essential roles during erythroid differentiation.
The roles of NMDA receptors in erythropoiesis and binding of Lrfn2 to NMDAR1 [1] led
us to hypothesize that the erythropoietic abnormalities in Lrfn2 KO were caused by alterations
in NMDA receptor function or calcium signaling (Fig 7). First, the decreased CFU-E may
reflect the impaired role of NMDAR1 in MEP [10]. This hypothesis is supported by increased
BFU-E in Lrfn2-overexpressing BM cells [8]. Together with the BFU-E decrease tendency in
Lrfn2 KO, CFU-E decrease might reflect the impaired differentiation from MEP to BFU-E.
Otherwise, CFU-E decrease could be associated with intracellular calcium signaling after stim-
ulation by interleukin-3 and granulocyte-macrophage colony-stimulating factor [27]. Second,
increased early erythroblasts (EryA) may reflect impaired differentiation into EryB and/or
EryC. Third, increased CD71 level in EryC may reflect impaired differentiation into EryC,
because the expression of CD71 on the cell surface decreases during the differentiation of EryB
to EryC in murine erythropoiesis [28]. NMDA receptor plays a dual role in the survival of
EryB and maintenance of calcium homeostasis during the differentiation of EryC into circulat-
ing erythrocytes [15]. Collectively, erythropoietic abnormalities in Lrfn2 KO can be explained
measurement. (A) Outline of the assay. (B) %ΔF/F values between no treatment and NMDA/glycine treatment (NMDA-untreated)
groups or those between NMDA/glycine treatment and NMDA/glycine treatment groups with MK-801 pretreatment (MK801-NMDA)
are shown for total erythroblasts (TER119+), pro-erythroblasts (proE), early erythroblasts (EryA), mid erythroblasts (EryB), and late
erythroblasts (EryC). Open bar, WT; closed bar, KO; error bar, SD. Each value from a mouse is indicated by circles. P values were
obtained by two tailed t-tests between WT and KO groups. P values (f-test) were obtained by f-test between WT and KO. �, P< 0.05;
���, P< 0.001 in one tailed t-tests for null hypothesis denote mean values equal to zero.
https://doi.org/10.1371/journal.pone.0245624.g005
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by assuming that NMDA receptor functions are altered in both the early phase (MEP stage),
and the late phase (EryB, and EryC stages).
At the individual level, there was no difference between the numbers of cells in femur and
erythroid (TER119+) cells in BM. This can explain the counteracting effects during MEP
Fig 6. Immunostaining of EPO receptor (EpoR). BM cells were immunostained with anti-EpoR antibody (green).
Nuclei were stained with DAPI (blue). (A) Representative images. Scale bar, 20 μm. (B) Quantification of the EpoR-
immunopositive signals (WT, n = 6 mice; KO, n = 5 mice). Open bar, WT; closed bar, KO; error bar, SD. Each value
from a mouse is indicated by circles. P values were obtained by two tailed t-tests between WT and KO.
https://doi.org/10.1371/journal.pone.0245624.g006
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(decreased counts of CFU-E and BFU-E cells) and EryB and EryC stages (apparently increased
counts of erythroid cells in BM due to delayed differentiation). However, we did not obtain
direct evidence to explain the increased circulating erythrocytes number in Lrfn2 KO mice in
this study. Nevertheless, increased EpoR expression in BM cells may be associated with ery-
throcytosis because EpoR is required to suppress apoptosis in later stages of erythroblast matu-
ration [29]. Moreover, NMDA receptors in mature erythrocytes may affect the life span of
erythrocytes. In mature human and rat erythrocytes, NMDA receptors impact cellular nitric
oxide synthase activity [9,20]. It is possible that altered NMDA receptor function affects the
life span of erythrocytes.
The decreased platelet volume in Lrfn2 KO mice indicates the involvement of Lrfn2 in
thrombopoiesis, in addition to its role in erythropoiesis. NMDAR1 is expressed in human BM
megakaryocytes [30], and MK-801 inhibits not only proplatelet formation in megakaryocytes
but also megakaryocytic differentiation from hematopoietic stem cells [31]. In mice, thrombo-
cytopenia has been described as a phenotype of NMDAR1 KO heterozygotes (Grin1-/+)
(Mouse Genome Informatics and the Wellcome Trust Sanger Institute Mouse Genetics Proj-
ect, http://www.informatics.jax.org/allele/genoview/MGI:5781633). Therefore, the decreased
platelet volume may also be explained by the altered function of NMDA receptor.
Although the above discussion focused on NMDA receptors to elucidate the hematopoietic
role of Lrfn2, we cannot exclude other possibilities at this point. Considering the low abun-
dance of both Lrfn2 and NMDA receptors in hematopoietic cells in comparison to those of
brains, it would be necessary to further address the hematopoietic role of NMDA receptors
using genetically modified mice for better understanding. To our knowledge, very few studies
have addressed the role of the so-called synapse adhesion molecules in hematopoiesis. It would
be interesting to investigate the roles of synaptic molecular complexes in hematopoiesis and
physiological regulation of blood cells.
Supporting information
S1 Fig. Cell number and size of Lrfn2 KO bone marrow. (left) BM cell number from a
femur. (right) mean cell diameter. WT, n = 14; KO, n = 13 mice at 6–12 M-old male. Live BM
Fig 7. Hypothetical model to explain the role of Lrfn2 in hematopoiesis. Possible roles of Lrfn2 (top), differentiation stages of
erythrocyte lineage (middle), and molecular marker expression profiles (bottom) are indicated. Black vertical arrows indicate the
major abnormalities in Lrfn2 KO mice described in this paper. MEP, megakaryocyte-erythroid progenitor cell; Mk,
megakaryocytes.
https://doi.org/10.1371/journal.pone.0245624.g007
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cells were analyzed after trypan blue staining using automated cell counter (TC20, Bio-Rad).
(PDF)
S2 Fig. Quantitative PCR analysis of mRNA levels. Total RNAs from FACS-fractionated
bone marrow cells were subjected to analysis. Cells derived from 5 M-old male mice. Values
were normalized to those of 18S ribosomal RNA. WT, n = 3 mice; KO, n = 3 mice. Open bar,
WT; closed bar, KO; error bar, SD. Each value from a mouse is indicated by circles. P values
were obtained by two tailed t-tests. BM cells were fractionated by BD FACSAria sorter (BD
Biosciences). RNA was isolated from the BM cells using TRIzol Reagent (Thermo Fisher).
cDNA was synthesized using SuperScript II Reverse Transcriptase (Thermo Fisher). Realtime
RT-PCR analysis was carried out using Power SYBR Green PCR Master Mix (Thermo Fisher),
QuantStudio 12K Flex Real-Time PCR System (Thermo Fisher).
(PDF)
S3 Fig. Hematoxylin & Eosin staining of bone marrow and spleen sections. Sections derived
from 5–6 M-old male mice. Scale bar, 50 μm. The tissues were fixed by immersion in 4% PFA,
0.1 M sodium phosphate buffer, pH 7.4, overnight at 4 ˚C, dehydrated in a graded series of eth-
anol, cleared in xylene, and embedded in paraffin blocks for light microscopy. Six-microme-
ter-thick sections of tissues were cut with a microtome, mounted on slides, and stained with
hematoxylin and eosin. Images were taken by BZ-X700 microscope (Keyence).
(PDF)
S1 Table. Hemogram of Lrfn2 KO mice. Complete blood count of male Lrfn2 WT and KO
mice aged 3 M (2.0–4.3 M-old; WT, n = 6; KO, n = 7), 6 M (5.8–7.2 M-old; WT, n = 5; KO,
n = 6), and 12 M (10.3–13.1 M-old; WT, n = 16; KO, n = 14). Results are indicated as the
mean ± SD. Percentages indicate changes in KO mice compared to the mean in WT mice (WT
mean = 100%). Italicized values indicate the P values obtained by two-tiered unpaired t-test.
Bold letters indicate the percentages and P values with significant differences between WT and
KO mice. WBC, leukocyte count; Lymph, lymphocyte count; Mono, monocyte count; Gran,
granulocyte count; Lymph%, percentage of lymphocytes in total leukocytes; Mono%, percent-
age of monocytes in total leukocytes; Gran%, percentage of granulocytes in total leukocytes;
RBC, erythrocyte count; HGB, hemoglobin concentration; HCT, hematocrit; MCV, mean cor-
puscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglo-
bin concentration; RDW; red cell (erythrocyte) distribution width; PLT, platelet count; MPV,
mean platelet volume; PDW, platelet distribution width; PCT, plateletcrit.
(PDF)
S2 Table. Flow cytometry analysis of Lrfn2 KO BM cells. BM cells from 18–22 M-old Lrfn2 WT
(n = 8) and KO (n = 7) mice were subjected to CD71/TER119 flow cytometry. Results are indicated
as the mean ± SD. Percentages indicate changes in KO mice, compared to the mean in WT mice
(WT mean = 100%). Italicized values indicate the P value obtained by two-tiered unpaired t-test.
Bold letters indicate the percentages and P values with significant differences between WT and KO.
Cell count, numbers of cells out of 10,000 living cells (7AAD-negative); CD71, mean immunofluores-
cence intensity (arbitrary unit) given by anti-CD71-PE; TER119, mean immunofluorescence inten-
sity (arbitrary unit) given by anti-Ter119-FITC; FSC, forward scatter area; SSC, side scatter area.
(PDF)
Acknowledgments
We thank Dr. Kazuo Yamamoto (Biomedical Research Support Center, Nagasaki University)
for his helpful advice.
PLOS ONE Erythropoiesis and erythroblastic NMDAR-mediated calcium influx in Lrfn2 KO mice
PLOS ONE | https://doi.org/10.1371/journal.pone.0245624 January 22, 2021 14 / 16
Author Contributions
Investigation: Ryuta Maekawa, Hideki Muto, Minoru Hatayama, Jun Aruga.
Writing – original draft: Jun Aruga.
Writing – review & editing: Jun Aruga.
References
1. Wang CY, Chang K, Petralia RS, Wang YX, Seabold GK, Wenthold RJ. A novel family of adhesion-like
molecules that interacts with the NMDA receptor. J Neurosci. 2006; 26(8):2174–83. https://doi.org/10.
1523/JNEUROSCI.3799-05.2006 PMID: 16495444.
2. Morimura N, Inoue T, Katayama K, Aruga J. Comparative analysis of structure, expression and PSD95-
binding capacity of Lrfn, a novel family of neuronal transmembrane proteins. Gene. 2006; 380(2):72–
83. https://doi.org/10.1016/j.gene.2006.05.014 PMID: 16828986.
3. Ko J, Kim S, Chung HS, Kim K, Han K, Kim H, et al. SALM synaptic cell adhesion-like molecules regu-
late the differentiation of excitatory synapses. Neuron. 2006; 50(2):233–45. https://doi.org/10.1016/j.
neuron.2006.04.005 PMID: 16630835.
4. Morimura N, Yasuda H, Yamaguchi K, Katayama KI, Hatayama M, Tomioka NH, et al. Autism-like
behaviours and enhanced memory formation and synaptic plasticity in Lrfn2/SALM1-deficient mice. Nat
Commun. 2017; 8:15800. https://doi.org/10.1038/ncomms15800 PMID: 28604739; PubMed Central
PMCID: PMC5472790.
5. Thevenon J, Souchay C, Seabold GK, Dygai-Cochet I, Callier P, Gay S, et al. Heterozygous deletion of
the LRFN2 gene is associated with working memory deficits. European journal of human genetics:
EJHG. 2015. https://doi.org/10.1038/ejhg.2015.221 PMID: 26486473.
6. Rautiainen MR, Paunio T, Repo-Tiihonen E, Virkkunen M, Ollila HM, Sulkava S, et al. Genome-wide
association study of antisocial personality disorder. Translational psychiatry. 2016; 6(9):e883. https://
doi.org/10.1038/tp.2016.155 PMID: 27598967; PubMed Central PMCID: PMC5048197.
7. Li Y, Kim R, Cho YS, Song WS, Kim D, Kim K, et al. Lrfn2-Mutant Mice Display Suppressed Synaptic
Plasticity and Inhibitory Synapse Development and Abnormal Social Communication and Startle
Response. J Neurosci. 2018; 38(26):5872–87. Epub 2018/05/26. https://doi.org/10.1523/JNEUROSCI.
3321-17.2018 PMID: 29798891; PubMed Central PMCID: PMC6595971.
8. Castellanos A, Lang G, Frampton J, Weston K. Regulation of erythropoiesis by the neuronal transmem-
brane protein Lrfn2. Experimental hematology. 2007; 35(5):724–34. https://doi.org/10.1016/j.exphem.
2007.02.004 PMID: 17577922.
9. Kalev-Zylinska ML, Hearn JI, Makhro A, Bogdanova A. N-Methyl-D-Aspartate Receptors in Hematopoi-
etic Cells: What Have We Learned? Front Physiol. 2020; 11:577. Epub 2020/07/07. https://doi.org/10.
3389/fphys.2020.00577 PMID: 32625106; PubMed Central PMCID: PMC7311790.
10. Hearn JI, Green TN, Chopra M, Nursalim YNS, Ladvanszky L, Knowlton N, et al. N-Methyl-D-Aspartate
Receptor Hypofunction in Meg-01 Cells Reveals a Role for Intracellular Calcium Homeostasis in Bal-
ancing Megakaryocytic-Erythroid Differentiation. Thromb Haemost. 2020; 120(4):671–86. Epub 2020/
04/15. https://doi.org/10.1055/s-0040-1708483 PMID: 32289863; PubMed Central PMCID:
PMC7286128.
11. Festing MF. On determining sample size in experiments involving laboratory animals. Lab Anim. 2018;
52(4):341–50. Epub 2018/01/10. https://doi.org/10.1177/0023677217738268 PMID: 29310487.
12. Golde WT, Gollobin P, Rodriguez LL. A rapid, simple, and humane method for submandibular bleeding
of mice using a lancet. Lab Anim (NY). 2005; 34(9):39–43. Epub 2005/10/01. https://doi.org/10.1038/
laban1005-39 PMID: 16195737.
13. Koulnis M, Pop R, Porpiglia E, Shearstone JR, Hidalgo D, Socolovsky M. Identification and analysis of
mouse erythroid progenitors using the CD71/TER119 flow-cytometric assay. J Vis Exp. 2011;(54).
Epub 2011/08/19. https://doi.org/10.3791/2809 PMID: 21847081; PubMed Central PMCID:
PMC3211121.
14. Chu HC, Lee HY, Huang YS, Tseng WL, Yen CJ, Cheng JC, et al. Erythroid differentiation is augmented
in Reelin-deficient K562 cells and homozygous reeler mice. FEBS Lett. 2014; 588(1):58–64. Epub
2013/11/19. https://doi.org/10.1016/j.febslet.2013.11.002 PMID: 24239537.
15. Hanggi P, Telezhkin V, Kemp PJ, Schmugge M, Gassmann M, Goede JS, et al. Functional plasticity of
the N-methyl-d-aspartate receptor in differentiating human erythroid precursor cells. Am J Physiol Cell
Physiol. 2015; 308(12):C993–C1007. Epub 2015/03/20. https://doi.org/10.1152/ajpcell.00395.2014
PMID: 25788577; PubMed Central PMCID: PMC4469746.
PLOS ONE Erythropoiesis and erythroblastic NMDAR-mediated calcium influx in Lrfn2 KO mice
PLOS ONE | https://doi.org/10.1371/journal.pone.0245624 January 22, 2021 15 / 16
16. Hiroyama T, Miharada K, Sudo K, Danjo I, Aoki N, Nakamura Y. Establishment of mouse embryonic
stem cell-derived erythroid progenitor cell lines able to produce functional red blood cells. PLoS One.
2008; 3(2):e1544. Epub 2008/02/07. https://doi.org/10.1371/journal.pone.0001544 PMID: 18253492;
PubMed Central PMCID: PMC2212133.
17. Li J, Hale J, Bhagia P, Xue F, Chen L, Jaffray J, et al. Isolation and transcriptome analyses of human
erythroid progenitors: BFU-E and CFU-E. Blood. 2014; 124(24):3636–45. Epub 2014/10/24. https://doi.
org/10.1182/blood-2014-07-588806 PMID: 25339359; PubMed Central PMCID: PMC4256913.
18. Spivak JL. Erythropoietin use and abuse. In: Roach RC, Wagner PD, Hackett PH, editors. Hypoxia:
From Genes to the Bedside. Boston, MA: Springer US; 2001. p. 207–24.
19. Tefferi A, Barbui T. Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-
stratification and management. American Journal of Hematology. 2015; 90(2):162–73. https://doi.org/
10.1002/ajh.23895 PMID: 25611051
20. Makhro A, Wang J, Vogel J, Boldyrev AA, Gassmann M, Kaestner L, et al. Functional NMDA receptors
in rat erythrocytes. Am J Physiol Cell Physiol. 2010; 298(6):C1315–25. Epub 2010/05/12. https://doi.
org/10.1152/ajpcell.00407.2009 PMID: 20457837.
21. Makhro A, Hanggi P, Goede JS, Wang J, Bruggemann A, Gassmann M, et al. N-methyl-D-aspartate
receptors in human erythroid precursor cells and in circulating red blood cells contribute to the intracellu-
lar calcium regulation. Am J Physiol Cell Physiol. 2013; 305(11):C1123–38. Epub 2013/09/21. https://
doi.org/10.1152/ajpcell.00031.2013 PMID: 24048732.
22. Cheung JY, Zhang XQ, Bokvist K, Tillotson DL, Miller BA. Modulation of calcium channels in human
erythroblasts by erythropoietin. Blood. 1997; 89(1):92–100. Epub 1997/01/01. PMID: 8978281.
23. Gillo B, Ma YS, Marks AR. Calcium influx in induced differentiation of murine erythroleukemia cells.
Blood. 1993; 81(3):783–92. Epub 1993/02/01. PMID: 7678999.
24. Cheung JY, Elensky MB, Brauneis U, Scaduto RC Jr., Bell LL, Tillotson DL, et al. Ion channels in
human erythroblasts. Modulation by erythropoietin. J Clin Invest. 1992; 90(5):1850–6. Epub 1992/11/
11. https://doi.org/10.1172/JCI116061 PMID: 1385476; PubMed Central PMCID: PMC443245.
25. Alexis C, Nicolas J, Yohann D, Hakim O-H, Julien D, Corinne G, et al. PIEZO1 activation delays ery-
throid differentiation of normal and hereditary xerocytosis-derived human progenitor cells. Haematolo-
gica. 2020; 105(3):610–22. https://doi.org/10.3324/haematol.2019.218503 PMID: 31413092
26. Wölwer CB, Pase LB, Russell SM, Humbert PO. Calcium Signaling Is Required for Erythroid Enucle-
ation. PLOS ONE. 2016; 11(1):e0146201. https://doi.org/10.1371/journal.pone.0146201 PMID:
26731108
27. Paredes-Gamero EJ, Barbosa CM, Ferreira AT. Calcium signaling as a regulator of hematopoiesis.
Front Biosci (Elite Ed). 2012; 4:1375–84. Epub 2011/12/29. https://doi.org/10.2741/467 PMID:
22201962.
28. Chen K, Liu J, Heck S, Chasis JA, An X, Mohandas N. Resolving the distinct stages in erythroid differen-
tiation based on dynamic changes in membrane protein expression during erythropoiesis. Proceedings
of the National Academy of Sciences. 2009; 106(41):17413. https://doi.org/10.1073/pnas.0909296106
PMID: 19805084
29. Malik J, Kim AR, Tyre KA, Cherukuri AR, Palis J. Erythropoietin critically regulates the terminal matura-
tion of murine and human primitive erythroblasts. Haematologica. 2013; 98(11):1778–87. Epub 2013/
07/31. https://doi.org/10.3324/haematol.2013.087361 PMID: 23894012; PubMed Central PMCID:
PMC3815180.
30. Genever PG, Wilkinson DJ, Patton AJ, Peet NM, Hong Y, Mathur A, et al. Expression of a functional N-
methyl-D-aspartate-type glutamate receptor by bone marrow megakaryocytes. Blood. 1999; 93
(9):2876–83. Epub 1999/04/27. PMID: 10216082.
31. Hitchcock IS, Skerry TM, Howard MR, Genever PG. NMDA receptor-mediated regulation of human
megakaryocytopoiesis. Blood. 2003; 102(4):1254–9. Epub 2003/03/22. https://doi.org/10.1182/blood-
2002-11-3553 PMID: 12649130.
PLOS ONE Erythropoiesis and erythroblastic NMDAR-mediated calcium influx in Lrfn2 KO mice
PLOS ONE | https://doi.org/10.1371/journal.pone.0245624 January 22, 2021 16 / 16
